Cellect Biotechnology Statistics Share Statistics Cellect Biotechnology has 9.8M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 9.8M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 36.01K, so 0% of the outstanding
shares have been sold short.
Short Interest 36.01K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios PE Ratio 0 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cellect Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position Current Ratio 0 Quick Ratio 0 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-746.87M Employee Count 12 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 1.88, so Cellect Biotechnology's
price volatility has been higher than the market average.
Beta 1.88 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 1,950,309
Income Statement
Revenue n/a Gross Profit n/a Operating Income n/a Net Income -8.96B EBITDA n/a EBIT n/a Earnings Per Share (EPS) -66902.5
Full Income Statement Balance Sheet The company has 18.11M in cash and 0 in
debt, giving a net cash position of 18.11M.
Cash & Cash Equivalents 18.11M Total Debt n/a Net Cash n/a Retained Earnings n/a Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -20.34M
and capital expenditures -123K, giving a free cash flow of -20.46M.
Operating Cash Flow -20.34M Capital Expenditures -123K Free Cash Flow -20.46M FCF Per Share n/a
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields APOP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for APOP.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 26, 2021. It was a
forward
split with a ratio of 2:1.
Last Split Date Oct 26, 2021 Split Type forward Split Ratio 2:1
Scores Altman Z-Score n/a Piotroski F-Score n/a
